Tema Oncology ETF (CANC:NASDAQ) closed at $41.29 on October 23, 2026, down 0.39% on the day. The stock trades 12.2% below its 52-week high of $47.00 and 37.4% above its 52-week low of $30.04. Tema Oncology ETF is part of the Miscellaneous sector.
In 252 trading sessions since October 23, 2025, CANC closed higher on 128 days (51%). Its best day was January 7, 2026 (+5.50%) and its worst was October 13, 2026 (-3.25%). It never moved 10% or more in a single session.
The Tema Oncology ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The Adviser will use internal research and analysis based on company disclosure (such as 10-K filings, company presentations, capital markets day presentations) and other publicly available sources (e.g., sell-side research, biotechnology industry publications etc.) to make this assessment. Example companies include large pharmaceutical firms, diagnostic focused businesses with products used to diagnose cancer (such as liquid biopsies or cancer genomic screening), medical device companies focused on cancer treatment, and healthcare service providers with a specific strategic focus on helping treat and manage cancer. Tema Oncology ETF (the Fund) seeks to provide longterm growth.
Find more stocks like CANC with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.